Gabriel Jones
About Gabriel Jones
Gabriel Jones is the CEO and Co-founder of Proprio, known for his extensive leadership experience in emerging technology and intellectual property law, particularly in AI and healthcare.
Gabriel Jones - CEO and Co-Founder of Proprio
Gabriel Jones holds the role of CEO and co-founder at Proprio, a company he co-founded in 2016. His collaborators in this venture include Dr. Samuel Browd from Seattle Children's Hospital, University of Washington professor Joshua Smith, and computer vision specialist James Youngquist. As Proprio's CEO, Gabriel plays a pivotal role in steering the company's vision and strategy.
Gabriel Jones' Expertise in AI and Healthcare
Gabriel Jones brings over a decade of experience in emerging technology and intellectual property law. He has developed specialized knowledge in artificial intelligence and healthcare, making him an asset in both fields. His extensive background allows him to navigate complex technological landscapes and legal frameworks, contributing significantly to the companies he has worked with.
Gabriel Jones' Career Background
Gabriel Jones began his professional journey in international trade, working in Japan and Washington, D.C. He later transitioned to Wall Street, where he was involved in large-scale mergers and acquisitions. This diverse career trajectory has equipped him with a broad understanding of both domestic and international business practices.
Gabriel Jones' Collaboration with Bill & Melinda Gates Foundation
During his career, Gabriel Jones has worked closely with high-profile clients such as Bill Gates and the leadership of Microsoft. While collaborating with the Bill & Melinda Gates Foundation, he played a key role in evaluating and developing emerging technologies for global health and technology initiatives. This work underscores his ability to contribute to large-scale, impactful projects.
Gabriel Jones' Board Memberships and Leadership Roles
Gabriel Jones has held seats on several influential boards, including the Washington Biotech and Biomedical Association and the Group Health Foundation during its acquisition by Kaiser. These roles have allowed him to contribute to strategic decisions and support the growth and development of the organizations he has been involved with.